But Trump can have one or the other — not both. And if his incoming administration succeeds in enacting the tariffs he’s ...
The percentage of adults suffering from diabetes across the world has doubled over the past three decades, the biggest rises ...
Jon Missin considers himself lucky. The 51-year-old from Northamptonshire, in central England, was diagnosed with incurable ...
MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
Six states will see price cuts for ACA (Obamacare) plans, but all the others will see at least some increases. Find out where ...
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Development Indo-Pacific RealEcon Bilateral development assistance has long been an important tool of American leadership.